共 9 条
[1]
Nitti VW(2013)Results of a randomized phase III trial of mirabegron in patients with overactive bladder J. Urol. 189 1388-1395
[2]
Khullar V(2013)Efficacy and tolerability of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial Eur. Urol. 63 283-295
[3]
Nitti VW(2013)Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies Int. J. Clin. Pract. 67 619-632
[4]
Nitti VW(2013)OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial J. Urol. 189 2186-2193
[5]
Labrie J(2013)Surgery versus physiotherapy for stress urinary incontinence N. Engl. J. Med. 369 1124-1133
[6]
Nager CW(2012)A randomized trial of urodynamic testing before stress-incontinence surgery N. Engl. J. Med. 366 1987-1997
[7]
Sirls LT(2013)The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery J. Urol. 189 204-209
[8]
Dmochowski RR(2010)Update of AUA guideline on the surgical management of female stress urinary incontinence J. Urol. 183 1906-1914
[9]
Nygaard I(2013)Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse JAMA 309 2016-2024